Peter transitioned to Raymond James from Merrill Lynch in October 2017. He is focused on portfolio management, hedging strategies, and individual security selection, specifically in the biotechnology sector. Peter is a graduate of the University of Michigan and earned Bachelor of Science degrees in Biology and Psychology. Peter later continued to graduate school studying biomedical engineering. Peter co-owned and operated two successful companies and has a strong background in health science. From 1999 to 2012, Peter played an active role in managing the investments for the businesses, which led to him also managing those for his close friends and family. After selling his interests in 2012, he transitioned into investment management to make it a full-time career.